Scarica l'app Stockscreener
1.16
3.33%
-0.04
Precedente Chiudi:
$1.20
Aprire:
$1.2
Volume 24 ore:
14,133
Relative Volume:
0.91
Capitalizzazione di mercato:
$13.57M
Reddito:
$3.37M
Utile/perdita netta:
$-57.28M
Rapporto P/E:
-0.1079
EPS:
-10.7522
Flusso di cassa netto:
$-51.83M
1 W Prestazione:
-9.38%
1M Prestazione:
-13.43%
6M Prestazione:
-23.68%
1 anno Prestazione:
-35.20%
Intervallo 1D:
$1.10
$1.20
Intervallo di 1 settimana:
$1.10
$1.3192
Portata 52W:
$1.10
$1.96
Synlogic Inc Stock (SYBX) Company Profile
Nome
Synlogic Inc
Settore
Industria
Telefono
617-659-2802
Indirizzo
PO BOX 30, WINCHESTER, MA
Confronta SYBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYBX
Synlogic Inc
|
1.16 | 13.57M | 3.37M | -57.28M | -51.83M | -10.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 66.76B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Synlogic Inc Stock (SYBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-11-24 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-08-21 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-30 | Iniziato | Jefferies | Buy |
| 2018-12-13 | Iniziato | Chardan Capital Markets | Buy |
| 2018-03-19 | Iniziato | H.C. Wainwright | Buy |
| 2018-01-29 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Synlogic Inc Borsa (SYBX) Ultime notizie
Synlogic’s executive Mary Beth Dooley sells $172 in common stock - Investing.com India
SYBX stock touches 52-week low at $1.14 amid market challenges - Investing.com Australia
Gallium Arsenide Market Applications and Semiconductor Industry Impact - openPR.com
Synlogic (NASDAQ:SYBX) Shares Pass Below Fifty Day Moving Average – Here’s Why - Defense World
SYBX stock touches 52-week low at $1.15 amid market challenges - Investing.com Australia
Synlogic (SYBX) to Release Quarterly Earnings on Tuesday - Defense World
Synlogic Inc. (SYBX) reports earnings - Quartz
5 Best Microbiome Companies (March 2025) - Securities.io
Week Ahead (Nov.2226): FDA Decision, Data Presentations (ABEO, SYBX, AADI…) - RTTNews
CRISPR and Cas Gene Market May Set a New Epic Growth Story | Fate Therapeutics, Cellectis, Synlogic - Newstrail
Microbiomes Market to Grow by USD 824.3 Million (2025-2029) with Rising Disease Prevalence Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
Synlogic's executive sells shares worth $2,802 - MSN
Synlogic's executive sells shares worth $2,802 By Investing.com - Investing.com South Africa
Promising Growth Expected in Gout Therapeutics Market, Set to Reach $5.03 Billion by 2029 with a CAGR of 11.7% - WhaTech
Synlogic (SYBX) Stock Price, News & Analysis - MarketBeat
Synlogic announces board member resignation By Investing.com - Investing.com Canada
Synlogic announces board member resignation - Investing.com
The definitive Boston biotech layoff tracker for 2024 - The Business Journals
Fmr LLC Trims Stock Holdings in Synlogic, Inc. (NASDAQ:SYBX) - Defense World
Biopolymers Market to Reach USD 47.4 Billion by 2032 Driven - GlobeNewswire
Synlogic (NASDAQ:SYBX) Trading Down 0.7% – What’s Next? - Defense World
Only the paranoid survive, and the CEO’s paradox, from Aoife Brennan - BioCentury
Urea Cycle Disorder Treatment Market to Grow by USD 215.4 Million (2024-2028), Driven by Rising Prevalence, with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve
Synlogic (FRA:MIN) 3-Year FCF Growth Rate : 21.90% (As of Sep. 2024) - GuruFocus.com
Synlogic (FRA:MIN) Momentum Rank : 2 (As of Nov. 30, 2024) - GuruFocus.com
Phenylketonuria Market size is ~700 USD million in 2023, asserts DelveInsight | Pharma Giants: PTC Therapeutics, Homology Medicines, Synlogic, BioMarin Pharmaceuticals - The Globe and Mail
Microbiomes Market to Grow by USD 1.13 Billion (2024-2028), Rising Disease Prevalence Driving Revenue, with AI Powering Market EvolutionTechnavio - The Malaysian Reserve
Synlogic Third Quarter 2024 Earnings: US$0.01 loss per share (vs US$2.57 loss in 3Q 2023) - Yahoo Finance
Synlogic Reports Q3 2024 Financial Outcomes - TipRanks
Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewswire
Synlogic (SYBX) Slashes Q3 Losses by 99% Amid Strategic Review, No Revenue | SYBX Stock News - StockTitan
The 2024 Biotech Graveyard - Fierce Biotech
Synlogic's head of finance Mary Beth Dooley sells $110 in stock - Investing.com
(PDF) The effects of caffeinated and decaffeinated coffee on sex hormone-binding globulin and endogenous sex hormone levels: A randomized controlled trial - ResearchGate
Oxygen Scavenger Market Set to Reach USD 8.2 Billion by - GlobeNewswire
Synlogic says co entered into sales agreement with Cowen And Company, LLC - Reuters
Renaissance Technologies LLC Decreases Position in Synlogic, Inc. (NASDAQ:SYBX) - Defense World
Urea Cycle Disorders Treatment Market Research In New Report - WhaTech
Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewswire
Otsuka snaps up Jnana with its phenylketonuria drug for $800m - Pharmaceutical Technology
Xilio Therapeutics Appoints Aoife Brennan and James Shannon to its Board of Directors - citybiz
Gut Microbiota Market Set to Reach a Staggering US$ 3,600.1 Million by 2032 - BioSpace
Synlogic Announces Termination Of Abbvie Collaboration Agreement - Reuters
Synlogic Reports First Quarter 2024 Financial Results - GlobeNewswire
Human Microbiome Market Size & Share to Surpass USD 2,555 million by 2030 - WhaTech
Synlogic Appoints James Flynn to Board Amidst Director Resignations - TipRanks
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire
Synlogic Announces Top Executive Departures and Compensation Deals - TipRanks
Synlogic adopts shareholder rights plan, eyes strategic options By Investing.com - Investing.com Canada
Irish-led Synlogic to cease operations after ending drug trial - Silicon Republic
Synlogic Announces Plan to Cease Operations and Reduce Its Workforce by More Than 90% - SynBioBeta
Synlogic Inc Azioni (SYBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):